Phase III immunology clinical trial starts growth rate
Global, 2024–2025 to 2025
-4%
2025
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from -4% to -4%. Latest value -4% (2025).
%
-4
-3
-2
-1
0
2024
2025
-4%
-4%
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from -4% to -4%. Latest value -4% (2025).
%
-4
-3
-2
-1
0
2024
2025
-4%
-4%
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from -4% to -4%. Latest value -4% (2025).
%
-4
-3
-2
-1
0
2024
2025
-4%
-4%
View the underlying data
Phase III immunology clinical trial starts growth rate: Global, 2024–2025 to 2025
Period
Type
Value
2024–2025
Actual
-4%
2025
Actual
-4%
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0